ORTHODONTIX FORM 10-KSB 12/31/2004

Company

Protalix BioTherapeutics, Inc.

Filed

March 31, 2005

Period of Report

December 31, 2004

Accession Number

0001006281-05-000001

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →